Informed Patient Decision Making and the Use of Prescription Medications: A Canadian Dermatologic Perspective

作者: Michael I. Singer , Neil H. Shear

DOI: 10.1177/120347549600100104

关键词: Perspective (graphical)Family medicineInformed consentMedical prescriptionPatient rightsObligationMedicineAutonomyAllegationLegal definition

摘要: Background:Informed consent is a potentially beneficial component of medical practice and basic obligation physician to patient. Society, in general, the courts, particular, have increasingly emphasized principles individual autonomy patient rights, they begun more rigorously require physicians inform consult with patients before initiating treatments. Nevertheless, lack sufficient information disclosure has become an common allegation legal actions against physicians. It been shown that physicians' understanding what constitutes informed not always equivalent definition. While generally applied investigative research surgical other invasive procedures, general medicine dermatology do commonly undergo process formal decision making commencing therapy sometimes potent medications often s...

参考文章(16)
Nightingale C, Philipson Sj, Gabram Sg, Doyle Ma, Philipson Eh, Informed consent for research: a study to evaluate readability and processability to effect change. Journal of Investigative Medicine. ,vol. 43, pp. 459- ,(1995)
Charles W. Lidz, Alan Meisel, Paul S. Appelbaum, Informed Consent: Legal Theory and Clinical Practice ,(1987)
Ruth R. Faden, Catherine Becker, Carol Lewis, John Freeman, Alan I. Faden, Disclosure of information to patients in medical care. Medical Care. ,vol. 19, pp. 718- 733 ,(1981) , 10.1097/00005650-198107000-00003
A W Asscher, G D Parr, V B Whitmarsh, Towards the safer use of medicines. BMJ. ,vol. 311, pp. 1003- 1006 ,(1995) , 10.1136/BMJ.311.7011.1003
Kimberly A. Quaid, Ruth R. Faden, Eileen P. Vining, John M. Freeman, Informed consent for a prescription drug: Impact of disclosed information on patient understanding and medical outcomes Patient Education and Counseling. ,vol. 15, pp. 249- 259 ,(1990) , 10.1016/0738-3991(90)90100-Y
Geoffrey C Lamb, Sandra S Green, James Heron, Can Physicians Warn Patients of Potential Side Effects Without Fear of Causing Those Side Effects? Archives of Internal Medicine. ,vol. 154, pp. 2753- 2756 ,(1994) , 10.1001/ARCHINTE.1994.00420230150018
Allen A. Mitchell, Carla M. Van Bennekom, Carol Louik, A Pregnancy-Prevention Program in Women of Childbearing Age Receiving Isotretinoin New England Journal of Medicine. ,vol. 333, pp. 101- 106 ,(1995) , 10.1056/NEJM199507133330206
Catherine Bouffides Walsh, This prescription may be hazardous to your health: who is accountable to the patient? Journal of Clinical Psychopharmacology. ,vol. 13, pp. 68- 70 ,(1993) , 10.1097/00004714-199302000-00009
T. M. Grundner, On the Readability of Surgical Consent Forms New England Journal of Medicine. ,vol. 302, pp. 900- 902 ,(1980) , 10.1056/NEJM198004173021606
Wanju S. Dai, James M. LaBraico, Robert S. Stern, Epidemiology of isotretinoin exposure during pregnancy. Journal of The American Academy of Dermatology. ,vol. 26, pp. 599- 606 ,(1992) , 10.1016/0190-9622(92)70088-W